Depression and somatic comorbidity;Depressie en somatische comorbiditeit

Nederlands Tijdschrift voor Geneeskunde

Volumn 154, Issue 15, 2010, Pages 722-727

  Penninx, Brenda W J H ^a   Van Dyck, Richard ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL OBESITY; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IATROGENIC DISEASE; INFLAMMATION; OBESITY; REVIEW;

EID: 77951569426     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord. 2002;72:227-236 (Pubitemid 35351282)
2. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763-2774 (Pubitemid 44871461)
3. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49:837-845
4. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31:2383-2390
5. Luppino F, de Wit L, Bouvy P, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220-229
6. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115:5349-5361
7. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008;5:466-475
8. Penninx BWJH, Beekman ATF, Smit JH, et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res. 2008;17:121-140
9. Licht CMM, de Geus EJC, Zitman FG, Hoogendijk WJG, van Dyck R, Penninx BWJH. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry. 2008;65:1358-1367 (Pubitemid 351292233)
10. Vreeburg SA, Hoogendijk WJG, van Pelt J, et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry. 2009;66:617-626
11. Licht CM, de Geus E, Seldenrijk A, et al. Depression is associated with decreased blood pressure but antidepressant use increases the risk for hypertension. Hypertension. 2009;53:631-638.
12. Van Reedt-Dortland AKB, Giltay EJ, van Veen T, Zitman FG, Penninx BW. The metabolic syndrome in subjects with anxiety and depression disorders. Acta Psychiatr Scand. Ter perse.
13. Van Reedt-Dortland A, Giltay E, van Veen T, Zitman F, Penninx BW. Serum lipids and lipoproteins in subjects with current or remitted major depressive disorder and controls: the Netherlands Study of Depression and Anxiety. J Clin Psychiatry. Ter perse
14. Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005;46:225-32.. (Pubitemid 41040350)
15. Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry. 1990;51:3-11.
16. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101-2107
17. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am. 1998;21:293-307.
18. Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord. 2000;24:S50-S55.
19. Rottenberg J. Cardiac vagal control in depression: a critical analysis. Biol Psychol. 2007;74:200-211 (Pubitemid 44969448)
20. Dowlati Y, Herrmann N, Swardfager W et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446-457
21. The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132-140
22. Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002;39:237-246
23. Vaccarino V, Lampert R, Bremner JD, et al. Depressive symptoms and heart rate variability: evidence for a shared genetic substrate in a study of twins. Psychosom Med. 2008;70:628-636
24. McCaffery JM, Papandonatos GD, Stanton C, Lloyd-Richardson EE, Niaura R. Depressive symptoms and cigarette smoking in twins from the National Longitudinal Study of Adolescent Health. Health Psychol. 2008;27:S207-S215.
25. De Moor MHM, Boomsma DI, Stubbe JH, Willemsen G, de Geus EJC. Testing causality in the association between regular exercise and symptoms of anxiety and depression. Arch Gen Psychiatry. 2008;65:897-905.
26. Taylor D. Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. Acta Psychiatr Scand. 2008;118:434-442
27. Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106-3116
28. Van Melle JP, de Jonge P, Honig A, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry. 2007;190:460-466 (Pubitemid 46868827)
29. Glassman A. Depression and cardiovascular disease. Pharmacopsychiatry. 2008;41:221-225
30. De Jonge P, Ormel J, van den Brink RH, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry. 2006;163:138-144 (Pubitemid 43050115)
31. Lamers F, de Jonge P, Nolen W, et al. Depressive subtypes in a large cohort study: finding from the NESDA study. J Clin Psychiatry. Ter perse.
32. De Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry. 2000;57:1071-1076 (Pubitemid 30078177)
33. Kendler KS, Fiske A, Gardner CO, Gatz M. Delineation of two genetic pathways to major depression. Biol Psychiatry. 2009;65:808-811
34. Zuidersma M, Doornbos B, De Jonge P. Standaard screening op depressie bij hartpatiënten nog niet zinvol. Ned Tijdschr Geneeskd. 2009;153:A157.